Atlas Trials

Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

Clinical trial NCT01926977 · COMPLETED

Trial details

NCT number
NCT01926977
Sponsor
Arshad Khanani
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration
Start date
2013-09-01
Primary completion
2014-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.